Gene Symbol | Gene ID | Gene Info |
---|---|---|
PATZ1
|
ENSG00000100105.13 | POZ/BTB and AT hook containing zinc finger 1 |
KLF4
|
ENSG00000136826.10 | Kruppel like factor 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_110266914_110267065 | KLF4 | 14226 | 0.219276 | -0.71 | 3.3e-02 | Click! |
chr9_110267392_110267558 | KLF4 | 14712 | 0.218606 | -0.53 | 1.4e-01 | Click! |
chr9_110310779_110311295 | KLF4 | 58274 | 0.129796 | -0.49 | 1.8e-01 | Click! |
chr9_110253387_110253828 | KLF4 | 844 | 0.661052 | -0.46 | 2.1e-01 | Click! |
chr9_110246144_110246295 | KLF4 | 5192 | 0.232793 | -0.41 | 2.7e-01 | Click! |
chr22_31739044_31739240 | PATZ1 | 2620 | 0.161952 | 0.46 | 2.1e-01 | Click! |
chr22_31740961_31741872 | PATZ1 | 346 | 0.760404 | 0.42 | 2.6e-01 | Click! |
chr22_31740782_31740933 | PATZ1 | 905 | 0.405718 | 0.40 | 2.9e-01 | Click! |
chr22_31739598_31740614 | PATZ1 | 1656 | 0.230069 | 0.20 | 6.0e-01 | Click! |
chr22_31738772_31738923 | PATZ1 | 2915 | 0.152098 | 0.05 | 9.0e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_228247282_228247590 | 4.40 |
ARF1 |
ADP-ribosylation factor 1 |
22925 |
0.12 |
chr7_6544048_6544357 | 3.45 |
KDELR2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
20329 |
0.12 |
chr12_4381475_4382675 | 3.44 |
CCND2 |
cyclin D2 |
863 |
0.52 |
chr17_76123581_76124282 | 3.32 |
TMC6 |
transmembrane channel-like 6 |
780 |
0.49 |
chr9_139694632_139695272 | 3.23 |
CCDC183 |
coiled-coil domain containing 183 |
4137 |
0.08 |
chr17_72733506_72734386 | 3.19 |
RAB37 |
RAB37, member RAS oncogene family |
575 |
0.59 |
chr17_73840046_73840332 | 3.16 |
UNC13D |
unc-13 homolog D (C. elegans) |
226 |
0.84 |
chr1_154980554_154980872 | 3.04 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5418 |
0.08 |
chr19_13206703_13207270 | 2.98 |
LYL1 |
lymphoblastic leukemia derived sequence 1 |
6695 |
0.11 |
chr1_161038546_161039545 | 2.95 |
ARHGAP30 |
Rho GTPase activating protein 30 |
411 |
0.65 |
chr7_63360438_63360674 | 2.91 |
ENSG00000263891 |
. |
890 |
0.66 |
chr14_105953334_105954468 | 2.82 |
CRIP1 |
cysteine-rich protein 1 (intestinal) |
647 |
0.53 |
chr19_872645_872938 | 2.80 |
CFD |
complement factor D (adipsin) |
13101 |
0.07 |
chr14_91882732_91883366 | 2.80 |
CCDC88C |
coiled-coil domain containing 88C |
641 |
0.78 |
chrX_78621891_78622920 | 2.76 |
ITM2A |
integral membrane protein 2A |
451 |
0.91 |
chr7_6543759_6544005 | 2.75 |
KDELR2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
20009 |
0.12 |
chr16_23846602_23847146 | 2.70 |
PRKCB |
protein kinase C, beta |
448 |
0.87 |
chr12_54784517_54785351 | 2.65 |
ZNF385A |
zinc finger protein 385A |
131 |
0.92 |
chr22_50242881_50243371 | 2.61 |
ZBED4 |
zinc finger, BED-type containing 4 |
4364 |
0.21 |
chr5_1105065_1105874 | 2.57 |
SLC12A7 |
solute carrier family 12 (potassium/chloride transporter), member 7 |
6681 |
0.19 |
chr10_99608959_99609709 | 2.56 |
GOLGA7B |
golgin A7 family, member B |
662 |
0.7 |
chr22_40058332_40058676 | 2.56 |
CACNA1I |
calcium channel, voltage-dependent, T type, alpha 1I subunit |
91746 |
0.07 |
chr11_64510621_64511071 | 2.55 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
415 |
0.76 |
chr19_14474047_14474891 | 2.52 |
CD97 |
CD97 molecule |
17499 |
0.14 |
chr9_131012810_131012961 | 2.51 |
ENSG00000264823 |
. |
5576 |
0.09 |
chr1_26644827_26645344 | 2.48 |
UBXN11 |
UBX domain protein 11 |
231 |
0.76 |
chr19_6481304_6482171 | 2.46 |
DENND1C |
DENN/MADD domain containing 1C |
27 |
0.95 |
chr16_3014681_3015078 | 2.46 |
KREMEN2 |
kringle containing transmembrane protein 2 |
357 |
0.69 |
chr20_62708665_62709256 | 2.44 |
RGS19 |
regulator of G-protein signaling 19 |
1885 |
0.17 |
chr16_56691251_56692352 | 2.43 |
MT1F |
metallothionein 1F |
54 |
0.92 |
chr17_36714613_36715266 | 2.43 |
SRCIN1 |
SRC kinase signaling inhibitor 1 |
4721 |
0.18 |
chr17_4542943_4543325 | 2.41 |
ALOX15 |
arachidonate 15-lipoxygenase |
43 |
0.96 |
chr19_1260409_1260809 | 2.39 |
CIRBP |
cold inducible RNA binding protein |
546 |
0.56 |
chr1_200991644_200992373 | 2.39 |
KIF21B |
kinesin family member 21B |
528 |
0.78 |
chr9_139685367_139685521 | 2.33 |
TMEM141 |
transmembrane protein 141 |
363 |
0.42 |
chr4_129732983_129734245 | 2.33 |
JADE1 |
jade family PHD finger 1 |
615 |
0.83 |
chr17_29814991_29815971 | 2.33 |
RAB11FIP4 |
RAB11 family interacting protein 4 (class II) |
355 |
0.83 |
chr14_99712277_99712758 | 2.32 |
AL109767.1 |
|
16768 |
0.21 |
chr17_75450125_75450790 | 2.30 |
SEPT9 |
septin 9 |
295 |
0.88 |
chr9_139924646_139924964 | 2.28 |
ABCA2 |
ATP-binding cassette, sub-family A (ABC1), member 2 |
2065 |
0.1 |
chr1_156785806_156786457 | 2.27 |
SH2D2A |
SH2 domain containing 2A |
495 |
0.51 |
chr1_6525804_6526081 | 2.27 |
TNFRSF25 |
tumor necrosis factor receptor superfamily, member 25 |
225 |
0.88 |
chr19_6767732_6768139 | 2.24 |
SH2D3A |
SH2 domain containing 3A |
336 |
0.81 |
chr1_1564774_1565122 | 2.23 |
MIB2 |
mindbomb E3 ubiquitin protein ligase 2 |
1079 |
0.29 |
chr6_130341588_130342312 | 2.20 |
L3MBTL3 |
l(3)mbt-like 3 (Drosophila) |
248 |
0.96 |
chr17_7239932_7240900 | 2.20 |
ACAP1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
507 |
0.51 |
chr17_56408210_56408765 | 2.20 |
MIR142 |
microRNA 142 |
192 |
0.87 |
chr19_49838375_49839003 | 2.18 |
CD37 |
CD37 molecule |
5 |
0.95 |
chr19_10405987_10406645 | 2.18 |
ICAM5 |
intercellular adhesion molecule 5, telencephalin |
4663 |
0.08 |
chr12_4380314_4380587 | 2.16 |
CCND2 |
cyclin D2 |
2488 |
0.24 |
chr13_114428270_114428568 | 2.15 |
TMEM255B |
transmembrane protein 255B |
33797 |
0.18 |
chr17_56410108_56410593 | 2.15 |
MIR142 |
microRNA 142 |
481 |
0.66 |
chr9_134152676_134153362 | 2.14 |
FAM78A |
family with sequence similarity 78, member A |
1085 |
0.5 |
chr11_20178120_20178396 | 2.14 |
DBX1 |
developing brain homeobox 1 |
3612 |
0.29 |
chr10_22609853_22610108 | 2.13 |
BMI1 |
BMI1 polycomb ring finger oncogene |
160 |
0.94 |
chr1_92950112_92951112 | 2.12 |
GFI1 |
growth factor independent 1 transcription repressor |
1016 |
0.65 |
chr11_117856643_117857627 | 2.12 |
IL10RA |
interleukin 10 receptor, alpha |
26 |
0.98 |
chr17_27039009_27039183 | 2.10 |
PROCA1 |
protein interacting with cyclin A1 |
224 |
0.75 |
chr6_391719_392776 | 2.10 |
IRF4 |
interferon regulatory factor 4 |
508 |
0.87 |
chr19_1077655_1078093 | 2.10 |
HMHA1 |
histocompatibility (minor) HA-1 |
432 |
0.68 |
chr19_11449786_11450552 | 2.10 |
RAB3D |
RAB3D, member RAS oncogene family |
175 |
0.88 |
chr17_81060660_81060811 | 2.10 |
METRNL |
meteorin, glial cell differentiation regulator-like |
8741 |
0.25 |
chr8_103819141_103819922 | 2.07 |
AZIN1 |
antizyme inhibitor 1 |
50799 |
0.11 |
chr12_122241648_122241827 | 2.06 |
SETD1B |
SET domain containing 1B |
349 |
0.75 |
chr16_29676024_29676411 | 2.06 |
QPRT |
quinolinate phosphoribosyltransferase |
1617 |
0.24 |
chr9_139948057_139948495 | 2.06 |
ENTPD2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
194 |
0.77 |
chr5_133801504_133801725 | 2.06 |
ENSG00000207222 |
. |
34361 |
0.12 |
chr16_2582259_2582985 | 2.05 |
ENSG00000266232 |
. |
616 |
0.38 |
chr17_43326081_43326290 | 2.04 |
CTD-2020K17.4 |
|
18 |
0.93 |
chr19_47760300_47760580 | 2.03 |
CCDC9 |
coiled-coil domain containing 9 |
349 |
0.83 |
chr1_161008159_161008677 | 2.02 |
TSTD1 |
thiosulfate sulfurtransferase (rhodanese)-like domain containing 1 |
101 |
0.93 |
chr19_42758223_42758597 | 2.02 |
ERF |
Ets2 repressor factor |
359 |
0.64 |
chr9_139926103_139926258 | 2.01 |
FUT7 |
fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
1282 |
0.17 |
chr19_19738537_19738987 | 2.00 |
LPAR2 |
lysophosphatidic acid receptor 2 |
153 |
0.92 |
chr11_2292275_2292426 | 1.99 |
ASCL2 |
achaete-scute family bHLH transcription factor 2 |
168 |
0.93 |
chr5_150465316_150465727 | 1.99 |
TNIP1 |
TNFAIP3 interacting protein 1 |
1198 |
0.49 |
chr20_24929736_24929887 | 1.98 |
CST7 |
cystatin F (leukocystatin) |
55 |
0.98 |
chr1_40157482_40157633 | 1.97 |
HPCAL4 |
hippocalcin like 4 |
196 |
0.61 |
chr8_37699008_37699734 | 1.97 |
BRF2 |
BRF2, RNA polymerase III transcription initiation factor 50 kDa subunit |
7985 |
0.16 |
chr10_126840512_126840747 | 1.97 |
CTBP2 |
C-terminal binding protein 2 |
6656 |
0.3 |
chr6_36098764_36099262 | 1.97 |
MAPK13 |
mitogen-activated protein kinase 13 |
573 |
0.74 |
chr15_77287809_77288285 | 1.95 |
PSTPIP1 |
proline-serine-threonine phosphatase interacting protein 1 |
132 |
0.96 |
chr12_70759576_70760191 | 1.94 |
KCNMB4 |
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
173 |
0.96 |
chr11_64107746_64107914 | 1.94 |
CCDC88B |
coiled-coil domain containing 88B |
135 |
0.9 |
chr1_155162943_155163205 | 1.94 |
MUC1 |
mucin 1, cell surface associated |
368 |
0.6 |
chr6_43243068_43244292 | 1.94 |
SLC22A7 |
solute carrier family 22 (organic anion transporter), member 7 |
22056 |
0.11 |
chr14_99713029_99713259 | 1.93 |
AL109767.1 |
|
16141 |
0.21 |
chrX_70330517_70330974 | 1.93 |
IL2RG |
interleukin 2 receptor, gamma |
553 |
0.61 |
chr12_7055489_7056183 | 1.92 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
63 |
0.9 |
chr20_37434091_37434759 | 1.89 |
PPP1R16B |
protein phosphatase 1, regulatory subunit 16B |
58 |
0.98 |
chr1_31221075_31221353 | 1.89 |
ENSG00000264773 |
. |
9135 |
0.16 |
chr3_47029501_47029908 | 1.88 |
CCDC12 |
coiled-coil domain containing 12 |
6232 |
0.19 |
chr1_154982220_154982994 | 1.86 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
4317 |
0.08 |
chr3_13920477_13920889 | 1.85 |
WNT7A |
wingless-type MMTV integration site family, member 7A |
935 |
0.64 |
chr19_3721754_3721946 | 1.83 |
TJP3 |
tight junction protein 3 |
115 |
0.93 |
chr14_91883760_91884222 | 1.82 |
CCDC88C |
coiled-coil domain containing 88C |
130 |
0.97 |
chr11_725898_726201 | 1.82 |
AP006621.9 |
|
998 |
0.31 |
chr19_49217598_49217896 | 1.82 |
MAMSTR |
MEF2 activating motif and SAP domain containing transcriptional regulator |
2353 |
0.14 |
chr2_113931617_113931842 | 1.81 |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
155 |
0.91 |
chr11_64511299_64511931 | 1.80 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
2 |
0.96 |
chr11_555293_555591 | 1.80 |
RP11-496I9.1 |
|
2153 |
0.13 |
chr21_45579276_45579734 | 1.78 |
AP001055.1 |
|
14075 |
0.13 |
chr19_39368685_39368907 | 1.78 |
RINL |
Ras and Rab interactor-like |
98 |
0.92 |
chr3_47023261_47023739 | 1.78 |
CCDC12 |
coiled-coil domain containing 12 |
28 |
0.97 |
chr17_6560192_6560644 | 1.77 |
ENSG00000264468 |
. |
1590 |
0.21 |
chr11_45943886_45945188 | 1.77 |
GYLTL1B |
glycosyltransferase-like 1B |
208 |
0.9 |
chr16_3086811_3087117 | 1.77 |
CCDC64B |
coiled-coil domain containing 64B |
37 |
0.91 |
chr20_30555715_30556040 | 1.75 |
XKR7 |
XK, Kell blood group complex subunit-related family, member 7 |
72 |
0.96 |
chr7_6543400_6543638 | 1.75 |
KDELR2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
19646 |
0.12 |
chr2_106886104_106886958 | 1.75 |
UXS1 |
UDP-glucuronate decarboxylase 1 |
75736 |
0.1 |
chr12_4380598_4381153 | 1.75 |
CCND2 |
cyclin D2 |
2063 |
0.27 |
chr11_65314232_65314500 | 1.74 |
LTBP3 |
latent transforming growth factor beta binding protein 3 |
136 |
0.91 |
chr16_23848119_23848415 | 1.74 |
PRKCB |
protein kinase C, beta |
277 |
0.93 |
chr1_228247617_228247954 | 1.74 |
ARF1 |
ADP-ribosylation factor 1 |
22576 |
0.12 |
chr15_75079322_75079822 | 1.74 |
CSK |
c-src tyrosine kinase |
1313 |
0.27 |
chr10_134260489_134261029 | 1.73 |
C10orf91 |
chromosome 10 open reading frame 91 |
2066 |
0.3 |
chr17_72209755_72210280 | 1.73 |
TTYH2 |
tweety family member 2 |
364 |
0.59 |
chr15_81589438_81589936 | 1.73 |
IL16 |
interleukin 16 |
433 |
0.84 |
chr17_80260072_80260536 | 1.73 |
CD7 |
CD7 molecule |
15124 |
0.1 |
chr20_62710337_62711142 | 1.72 |
RGS19 |
regulator of G-protein signaling 19 |
106 |
0.88 |
chr10_75757286_75757724 | 1.72 |
VCL |
vinculin |
367 |
0.86 |
chr20_62272194_62272345 | 1.72 |
STMN3 |
stathmin-like 3 |
11850 |
0.09 |
chr1_209943004_209943387 | 1.71 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
1235 |
0.37 |
chr19_39227082_39227399 | 1.71 |
CAPN12 |
calpain 12 |
1178 |
0.28 |
chr9_134154077_134154228 | 1.71 |
FAM78A |
family with sequence similarity 78, member A |
2218 |
0.29 |
chr20_44633478_44633997 | 1.71 |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
3810 |
0.15 |
chr17_7788638_7788948 | 1.70 |
LSMD1 |
LSM domain containing 1 |
266 |
0.71 |
chr15_83349304_83349679 | 1.70 |
AP3B2 |
adaptor-related protein complex 3, beta 2 subunit |
18501 |
0.12 |
chr12_4382982_4383628 | 1.70 |
CCND2 |
cyclin D2 |
367 |
0.72 |
chr14_22538566_22539116 | 1.69 |
ENSG00000238634 |
. |
72046 |
0.12 |
chr1_154981282_154981433 | 1.69 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5567 |
0.08 |
chr7_5572395_5572659 | 1.69 |
ACTB |
actin, beta |
2187 |
0.2 |
chr1_9712713_9712881 | 1.69 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
994 |
0.46 |
chr20_48806660_48807137 | 1.68 |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
478 |
0.82 |
chr1_206732155_206732306 | 1.68 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
1737 |
0.33 |
chr12_4381277_4381428 | 1.67 |
CCND2 |
cyclin D2 |
1586 |
0.32 |
chrX_129225814_129226276 | 1.67 |
ELF4 |
E74-like factor 4 (ets domain transcription factor) |
18291 |
0.19 |
chr19_17858967_17859176 | 1.67 |
FCHO1 |
FCH domain only 1 |
500 |
0.71 |
chr7_149469463_149469788 | 1.67 |
ZNF467 |
zinc finger protein 467 |
683 |
0.72 |
chr16_30197801_30198230 | 1.66 |
RP11-455F5.5 |
|
1737 |
0.15 |
chr1_25255138_25255978 | 1.66 |
RUNX3 |
runt-related transcription factor 3 |
54 |
0.98 |
chr16_30484849_30485032 | 1.66 |
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
382 |
0.62 |
chr7_128578118_128579002 | 1.66 |
IRF5 |
interferon regulatory factor 5 |
289 |
0.89 |
chr10_135148565_135149526 | 1.65 |
CALY |
calcyon neuron-specific vesicular protein |
1331 |
0.22 |
chr20_3732582_3733178 | 1.65 |
C20orf27 |
chromosome 20 open reading frame 27 |
6445 |
0.13 |
chr7_45018291_45018491 | 1.64 |
MYO1G |
myosin IG |
306 |
0.85 |
chr19_8641850_8642121 | 1.64 |
MYO1F |
myosin IF |
337 |
0.81 |
chr5_180230026_180230861 | 1.63 |
MGAT1 |
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
38 |
0.97 |
chr16_89034541_89034870 | 1.63 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
8696 |
0.15 |
chr17_43972439_43972776 | 1.63 |
MAPT-AS1 |
MAPT antisense RNA 1 |
272 |
0.72 |
chr16_744958_745211 | 1.62 |
FBXL16 |
F-box and leucine-rich repeat protein 16 |
941 |
0.23 |
chr3_5028227_5029021 | 1.62 |
BHLHE40-AS1 |
BHLHE40 antisense RNA 1 |
6978 |
0.21 |
chr19_6464115_6464545 | 1.62 |
CRB3 |
crumbs homolog 3 (Drosophila) |
36 |
0.92 |
chr5_131831286_131831908 | 1.62 |
IRF1 |
interferon regulatory factor 1 |
5107 |
0.15 |
chr22_20286616_20287157 | 1.61 |
XXbac-B444P24.13 |
|
19386 |
0.11 |
chr8_146051844_146052235 | 1.61 |
ZNF7 |
zinc finger protein 7 |
810 |
0.48 |
chr20_826611_826818 | 1.61 |
FAM110A |
family with sequence similarity 110, member A |
947 |
0.64 |
chr7_2551277_2551522 | 1.61 |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
764 |
0.61 |
chr19_44283632_44284486 | 1.61 |
KCNN4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
1350 |
0.33 |
chr5_141736101_141736639 | 1.61 |
AC005592.2 |
|
3262 |
0.31 |
chr19_6801414_6802010 | 1.60 |
VAV1 |
vav 1 guanine nucleotide exchange factor |
17583 |
0.13 |
chr14_104338356_104339113 | 1.60 |
PPP1R13B |
protein phosphatase 1, regulatory subunit 13B |
24807 |
0.13 |
chr15_89943256_89943512 | 1.60 |
ENSG00000207819 |
. |
32136 |
0.15 |
chr1_2347262_2347748 | 1.60 |
PEX10 |
peroxisomal biogenesis factor 10 |
2269 |
0.17 |
chr9_132250392_132250679 | 1.59 |
ENSG00000264298 |
. |
9700 |
0.22 |
chr19_1470719_1471158 | 1.59 |
C19orf25 |
chromosome 19 open reading frame 25 |
7958 |
0.07 |
chr4_2538188_2538339 | 1.59 |
RNF4 |
ring finger protein 4 |
46725 |
0.12 |
chr17_4403063_4403461 | 1.58 |
AC118754.4 |
|
293 |
0.8 |
chr2_127838932_127839401 | 1.58 |
BIN1 |
bridging integrator 1 |
25411 |
0.22 |
chr19_1074414_1074782 | 1.58 |
HMHA1 |
histocompatibility (minor) HA-1 |
2844 |
0.13 |
chr19_19651567_19652157 | 1.58 |
CILP2 |
cartilage intermediate layer protein 2 |
2788 |
0.16 |
chr22_37545294_37545803 | 1.58 |
IL2RB |
interleukin 2 receptor, beta |
482 |
0.7 |
chr9_139439215_139440028 | 1.58 |
NOTCH1 |
notch 1 |
693 |
0.35 |
chr1_1982068_1982219 | 1.58 |
PRKCZ |
protein kinase C, zeta |
104 |
0.89 |
chr1_27669467_27669709 | 1.58 |
SYTL1 |
synaptotagmin-like 1 |
131 |
0.93 |
chr6_130341357_130341579 | 1.57 |
L3MBTL3 |
l(3)mbt-like 3 (Drosophila) |
168 |
0.97 |
chr20_4803550_4804195 | 1.57 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
419 |
0.85 |
chr1_155099455_155100757 | 1.56 |
EFNA1 |
ephrin-A1 |
170 |
0.86 |
chr1_1136399_1136824 | 1.55 |
TNFRSF18 |
tumor necrosis factor receptor superfamily, member 18 |
4449 |
0.09 |
chr8_22552129_22552945 | 1.55 |
EGR3 |
early growth response 3 |
1722 |
0.26 |
chr19_46519362_46519696 | 1.54 |
ENSG00000211580 |
. |
2661 |
0.18 |
chr9_34591301_34591802 | 1.54 |
CNTFR |
ciliary neurotrophic factor receptor |
1430 |
0.24 |
chr12_1100531_1100778 | 1.54 |
ERC1 |
ELKS/RAB6-interacting/CAST family member 1 |
134 |
0.7 |
chr11_33722116_33722408 | 1.54 |
C11orf91 |
chromosome 11 open reading frame 91 |
24 |
0.97 |
chr3_193852202_193852818 | 1.54 |
HES1 |
hes family bHLH transcription factor 1 |
1424 |
0.4 |
chrX_118815979_118816490 | 1.54 |
SEPT6 |
septin 6 |
10558 |
0.17 |
chr8_103251470_103251823 | 1.53 |
KB-431C1.4 |
|
24 |
0.81 |
chr11_2322356_2322739 | 1.53 |
C11orf21 |
chromosome 11 open reading frame 21 |
596 |
0.44 |
chr1_6086993_6087271 | 1.53 |
KCNAB2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
225 |
0.93 |
chrX_149108264_149108672 | 1.53 |
LINC00894 |
long intergenic non-protein coding RNA 894 |
94 |
0.95 |
chr22_20784096_20784540 | 1.52 |
SCARF2 |
scavenger receptor class F, member 2 |
7794 |
0.11 |
chr9_132176299_132176863 | 1.52 |
ENSG00000242281 |
. |
43841 |
0.14 |
chr19_42703347_42703984 | 1.52 |
ENSG00000265122 |
. |
6435 |
0.1 |
chr4_90228457_90229530 | 1.52 |
GPRIN3 |
GPRIN family member 3 |
168 |
0.97 |
chr19_4369238_4370147 | 1.52 |
AC007292.6 |
|
5906 |
0.08 |
chr8_37754904_37755445 | 1.51 |
RAB11FIP1 |
RAB11 family interacting protein 1 (class I) |
1798 |
0.27 |
chr6_32159695_32160229 | 1.51 |
GPSM3 |
G-protein signaling modulator 3 |
683 |
0.42 |
chr11_129685784_129686044 | 1.51 |
TMEM45B |
transmembrane protein 45B |
200 |
0.97 |
chr16_77245971_77246665 | 1.50 |
SYCE1L |
synaptonemal complex central element protein 1-like |
172 |
0.95 |
chr8_22437078_22437527 | 1.50 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
362 |
0.75 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.9 | 5.6 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
1.8 | 8.9 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
1.8 | 5.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
1.6 | 6.2 | GO:0034063 | stress granule assembly(GO:0034063) |
1.5 | 7.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.4 | 4.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.4 | 4.1 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
1.3 | 4.0 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
1.3 | 4.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
1.3 | 3.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.3 | 3.8 | GO:0001821 | histamine secretion(GO:0001821) |
1.3 | 5.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.3 | 3.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.2 | 2.4 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.2 | 1.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
1.1 | 12.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
1.1 | 4.4 | GO:0048541 | Peyer's patch development(GO:0048541) |
1.1 | 5.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.1 | 3.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.0 | 3.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.0 | 2.0 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
1.0 | 3.0 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.0 | 1.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
1.0 | 2.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
1.0 | 1.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.9 | 3.7 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.9 | 1.9 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.9 | 5.5 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.9 | 0.9 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.9 | 4.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.9 | 2.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.9 | 0.9 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.9 | 5.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.9 | 2.6 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.9 | 4.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.9 | 3.5 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.9 | 2.6 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.8 | 1.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.8 | 2.5 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.8 | 2.5 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.8 | 0.8 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.8 | 3.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.8 | 3.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.8 | 4.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.8 | 2.4 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.8 | 0.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.8 | 2.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.8 | 2.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.8 | 3.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.8 | 2.3 | GO:0097205 | regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
0.8 | 0.8 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.8 | 2.3 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.8 | 0.8 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.8 | 2.3 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.8 | 2.3 | GO:0048143 | astrocyte activation(GO:0048143) |
0.8 | 0.8 | GO:0007143 | female meiotic division(GO:0007143) |
0.8 | 3.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.8 | 2.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.8 | 3.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.8 | 2.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.8 | 3.0 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.7 | 1.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.7 | 1.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.7 | 0.7 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.7 | 16.7 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.7 | 2.1 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.7 | 3.5 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.7 | 1.4 | GO:0001705 | ectoderm formation(GO:0001705) |
0.7 | 5.6 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.7 | 2.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.7 | 1.4 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.7 | 0.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.7 | 12.3 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.7 | 1.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.7 | 2.0 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.7 | 0.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.7 | 0.7 | GO:0060556 | regulation of vitamin metabolic process(GO:0030656) vitamin D biosynthetic process(GO:0042368) regulation of vitamin D biosynthetic process(GO:0060556) regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.7 | 1.3 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.7 | 2.7 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.6 | 1.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 3.2 | GO:0043368 | positive T cell selection(GO:0043368) |
0.6 | 3.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.6 | 3.2 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.6 | 0.6 | GO:0001743 | optic placode formation(GO:0001743) |
0.6 | 0.6 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.6 | 1.9 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.6 | 1.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.6 | 1.9 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.6 | 0.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.6 | 2.5 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.6 | 2.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 1.9 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.6 | 0.6 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.6 | 2.4 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.6 | 1.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 0.6 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.6 | 4.8 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.6 | 1.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.6 | 0.6 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.6 | 1.8 | GO:0002715 | regulation of natural killer cell mediated immunity(GO:0002715) positive regulation of natural killer cell mediated immunity(GO:0002717) regulation of natural killer cell mediated cytotoxicity(GO:0042269) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.6 | 2.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.6 | 1.8 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.6 | 9.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.6 | 0.6 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.6 | 2.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 0.6 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.6 | 1.8 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.6 | 3.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 1.2 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.6 | 1.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.6 | 1.7 | GO:0015809 | arginine transport(GO:0015809) |
0.6 | 1.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.6 | 1.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.6 | 1.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.6 | 1.7 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.6 | 2.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.6 | 1.1 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.6 | 1.1 | GO:0051322 | anaphase(GO:0051322) |
0.6 | 0.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.6 | 1.1 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.5 | 2.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.5 | 1.6 | GO:0033622 | integrin activation(GO:0033622) |
0.5 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.5 | 2.2 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.5 | 0.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.5 | 1.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 3.8 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.5 | 0.5 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 1.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.5 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 3.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.5 | 2.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 2.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.5 | 0.5 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.5 | 5.2 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.5 | 1.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.5 | 1.0 | GO:0035246 | peptidyl-arginine methylation(GO:0018216) peptidyl-arginine N-methylation(GO:0035246) |
0.5 | 4.6 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.5 | 1.5 | GO:0045007 | depurination(GO:0045007) |
0.5 | 1.0 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.5 | 5.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.5 | 3.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.5 | 1.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.5 | 1.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.5 | 1.5 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.5 | 2.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.5 | 0.5 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 5.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.5 | 1.0 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.5 | 2.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.5 | 1.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.5 | 2.5 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.5 | 1.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.5 | 6.9 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.5 | 2.5 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.5 | 0.5 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.5 | 1.5 | GO:0052257 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) |
0.5 | 1.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.5 | 1.5 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.5 | 0.5 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.5 | 3.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.5 | 1.9 | GO:0048664 | neuron fate determination(GO:0048664) |
0.5 | 0.5 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.5 | 2.9 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.5 | 0.5 | GO:1902305 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.5 | 2.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 0.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.5 | 1.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.5 | 1.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 1.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.5 | 1.4 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.5 | 0.5 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.5 | 0.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.5 | 1.4 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.5 | 2.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 0.5 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.5 | 0.5 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.5 | 0.9 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.5 | 1.4 | GO:0045056 | transcytosis(GO:0045056) |
0.5 | 3.7 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.5 | 2.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.5 | 0.5 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.5 | 3.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.5 | 1.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 1.4 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.4 | 2.2 | GO:0034311 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.4 | 1.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 0.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.4 | 4.0 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.4 | 1.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.4 | 7.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.4 | 0.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 0.9 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.4 | 1.3 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.4 | 0.9 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.4 | 0.9 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.4 | 2.6 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.4 | 0.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 1.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.4 | 1.7 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.4 | 0.4 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.4 | 1.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 1.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.4 | 1.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.4 | 0.8 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.4 | 0.8 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.4 | 2.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 1.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.4 | 3.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.4 | 3.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 1.2 | GO:0090200 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.4 | 2.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.4 | 0.8 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.4 | 1.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 3.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.4 | 0.4 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.4 | 2.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.4 | 1.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.4 | 0.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.4 | 0.8 | GO:0019042 | viral latency(GO:0019042) |
0.4 | 2.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 0.8 | GO:0042921 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.4 | 1.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.4 | 0.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 0.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.4 | 1.2 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.4 | 0.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.4 | 0.8 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 1.2 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.4 | 1.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 1.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.4 | 0.8 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.4 | 4.7 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.4 | 0.8 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.4 | 1.2 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.4 | 1.9 | GO:0002063 | chondrocyte development(GO:0002063) |
0.4 | 1.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.4 | 7.3 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.4 | 1.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.4 | 0.4 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.4 | 1.1 | GO:0060179 | male courtship behavior(GO:0008049) male mating behavior(GO:0060179) |
0.4 | 1.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 1.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.4 | 0.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.4 | 1.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.4 | 1.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.4 | 1.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.4 | 2.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.4 | 1.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.4 | 1.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.4 | 4.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.4 | 1.5 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.4 | 0.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.4 | 1.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 16.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.4 | 0.4 | GO:0060214 | endocardium formation(GO:0060214) |
0.4 | 1.5 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.4 | 1.5 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.4 | 0.4 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.4 | 1.5 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.4 | 1.9 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.4 | 1.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 14.0 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.4 | 1.5 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.4 | 3.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.4 | 1.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 1.8 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.4 | 0.4 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.4 | 0.7 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.4 | 1.5 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.4 | 1.5 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.4 | 1.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 | 0.4 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.4 | 1.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.4 | 0.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.4 | 0.4 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.4 | 2.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.4 | 1.1 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.4 | 0.7 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.4 | 1.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.4 | 1.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 1.4 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.4 | 1.1 | GO:0043276 | anoikis(GO:0043276) |
0.4 | 1.4 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.4 | 5.3 | GO:1902583 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.4 | 4.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 6.0 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.3 | 2.4 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.3 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 2.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.3 | 1.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 1.0 | GO:0070295 | renal water absorption(GO:0070295) |
0.3 | 1.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 1.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.3 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 3.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 1.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.3 | 2.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 0.3 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.3 | 0.7 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.3 | 1.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 0.3 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.3 | 2.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 0.7 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.3 | 0.7 | GO:0021702 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.3 | 1.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 0.3 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.3 | 1.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 1.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 5.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.3 | 0.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.3 | 1.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.7 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.3 | 1.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 2.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.3 | 8.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 1.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.6 | GO:0014897 | cardiac muscle hypertrophy(GO:0003300) striated muscle hypertrophy(GO:0014897) |
0.3 | 1.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 0.3 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.3 | 3.9 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 1.0 | GO:0010447 | response to acidic pH(GO:0010447) |
0.3 | 1.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.3 | 3.2 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 3.2 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.3 | 2.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 0.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.3 | 1.3 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.3 | 0.6 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.3 | 0.6 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.3 | 1.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.6 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.3 | 0.3 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.3 | 0.6 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 1.0 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 0.6 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.3 | 0.9 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.3 | 0.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 4.1 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.3 | 0.9 | GO:0002507 | tolerance induction(GO:0002507) |
0.3 | 1.9 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.3 | 0.6 | GO:0046543 | thelarche(GO:0042695) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 0.3 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 3.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.3 | 0.3 | GO:0001881 | receptor recycling(GO:0001881) |
0.3 | 0.9 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 | 3.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 0.9 | GO:0009301 | snRNA transcription(GO:0009301) |
0.3 | 0.6 | GO:0045010 | actin nucleation(GO:0045010) |
0.3 | 2.8 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.3 | 0.6 | GO:0046666 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 0.3 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) |
0.3 | 0.9 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.3 | 0.6 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.3 | 0.3 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.3 | 3.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.3 | 0.6 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 0.9 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.3 | 0.3 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 0.6 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.3 | 0.6 | GO:0060896 | neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
0.3 | 2.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 5.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 1.5 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 1.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 1.8 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.3 | 0.3 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.3 | 1.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.3 | 2.6 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.3 | 0.9 | GO:0000239 | pachytene(GO:0000239) |
0.3 | 1.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.3 | 7.5 | GO:0030183 | B cell differentiation(GO:0030183) |
0.3 | 1.2 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.3 | 0.3 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.3 | 0.3 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.3 | 1.2 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.3 | 0.9 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 6.6 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 0.6 | GO:0003179 | heart valve development(GO:0003170) atrioventricular valve development(GO:0003171) heart valve morphogenesis(GO:0003179) atrioventricular valve morphogenesis(GO:0003181) |
0.3 | 1.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 0.9 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 1.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.3 | 2.6 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.3 | 3.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 13.7 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.3 | 0.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 1.1 | GO:1902808 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 1.4 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 5.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 0.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.8 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.3 | 1.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.8 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.3 | 0.6 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.3 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 1.4 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.3 | 0.8 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.3 | 2.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 2.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 0.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 1.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 2.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.3 | 0.8 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.3 | 0.8 | GO:0016577 | histone demethylation(GO:0016577) |
0.3 | 0.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 2.5 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.3 | 1.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 2.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 1.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 3.0 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.3 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 2.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.3 | 0.5 | GO:0051136 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 1.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 0.3 | GO:0060124 | regulation of growth hormone secretion(GO:0060123) positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 1.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 0.3 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.3 | 0.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.3 | 0.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 1.6 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.3 | 8.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.3 | 0.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 1.0 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.3 | 0.5 | GO:0033197 | response to vitamin E(GO:0033197) |
0.3 | 2.8 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.3 | 1.3 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.5 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.3 | 0.8 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.3 | 4.6 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.3 | 0.3 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.3 | 0.5 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.3 | 1.3 | GO:0006110 | regulation of glycolytic process(GO:0006110) regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.3 | 1.8 | GO:1903311 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.3 | 1.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.3 | 0.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 7.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 2.5 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.2 | 2.7 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.2 | 2.0 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.2 | 1.5 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.2 | 45.2 | GO:0016568 | chromatin modification(GO:0016568) |
0.2 | 0.5 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.2 | 0.2 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.2 | 1.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 1.2 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.2 | 1.0 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.2 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.7 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.2 | 2.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.2 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.2 | 0.7 | GO:0043137 | lagging strand elongation(GO:0006273) DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.2 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.2 | 0.2 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.2 | 1.4 | GO:0031503 | protein complex localization(GO:0031503) |
0.2 | 1.0 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.7 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.2 | 1.9 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 1.4 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.2 | 1.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.2 | 2.6 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.2 | 1.9 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 4.0 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.2 | 0.5 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 0.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.2 | 0.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 0.9 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 0.5 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 1.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 5.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.2 | 1.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.7 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.2 | 1.4 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.2 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.2 | 0.9 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 2.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 1.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.2 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.2 | 0.7 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 9.2 | GO:0006914 | autophagy(GO:0006914) |
0.2 | 0.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 1.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.7 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.2 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 1.8 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.2 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 0.4 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 6.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 0.7 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 2.4 | GO:0034620 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.2 | 0.7 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 0.7 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 1.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 1.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.2 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
0.2 | 0.9 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.9 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.2 | 0.9 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.4 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 0.8 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 1.3 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.2 | 5.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 0.6 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.2 | 0.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.2 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.2 | 3.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.2 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.2 | 0.6 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.2 | 0.8 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.2 | 1.5 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 21.8 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.2 | 0.4 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.2 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.2 | 1.7 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 1.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 0.6 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.2 | 16.2 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
0.2 | 1.8 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 1.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.8 | GO:0015853 | adenine transport(GO:0015853) |
0.2 | 0.2 | GO:0090311 | regulation of protein deacetylation(GO:0090311) positive regulation of protein deacetylation(GO:0090312) |
0.2 | 1.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 3.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 0.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 1.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.6 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.2 | 0.6 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.2 | 4.4 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.2 | 9.1 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.2 | 0.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 1.0 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.2 | 0.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 3.9 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 0.6 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 0.8 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 0.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 0.8 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.2 | 0.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.2 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.2 | 1.4 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 1.4 | GO:0072676 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.2 | 7.1 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.2 | 1.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 19.4 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.2 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 2.5 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.2 | 0.4 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.2 | 0.2 | GO:0043558 | regulation of translation in response to stress(GO:0043555) regulation of translational initiation in response to stress(GO:0043558) |
0.2 | 2.3 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.2 | 0.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 1.1 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.2 | 0.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 1.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.2 | 5.9 | GO:0000910 | cytokinesis(GO:0000910) |
0.2 | 0.4 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 2.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.2 | 1.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.9 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 9.4 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 0.2 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.2 | 13.0 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.2 | 4.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.5 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.2 | 0.2 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.2 | 0.5 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.2 | 0.7 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.2 | 0.9 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.2 | 5.4 | GO:0015992 | proton transport(GO:0015992) |
0.2 | 0.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 | 0.4 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.9 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.2 | 0.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.9 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.2 | 0.5 | GO:0007140 | male meiosis(GO:0007140) |
0.2 | 0.2 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 3.9 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.2 | 1.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 1.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 0.2 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.2 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.2 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.2 | 0.5 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.2 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.3 | GO:0031929 | TOR signaling(GO:0031929) |
0.2 | 1.0 | GO:0052803 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.2 | 0.5 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.3 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.2 | 0.5 | GO:0006473 | protein acetylation(GO:0006473) |
0.2 | 0.2 | GO:0006818 | hydrogen transport(GO:0006818) |
0.2 | 1.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 2.9 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.2 | 0.2 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.2 | 0.3 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.2 | 0.8 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.2 | 0.2 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.2 | 0.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 11.1 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.2 | 0.8 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.2 | 1.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 4.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.6 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.2 | 1.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 0.6 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 0.6 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.2 | 0.2 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.5 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 1.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.8 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.2 | 0.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 3.4 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.2 | 0.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 2.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 1.4 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.2 | 0.5 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 1.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 2.6 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.1 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.1 | 1.6 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.6 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.3 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.1 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 4.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.1 | 0.1 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.1 | 1.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.7 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.9 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.4 | GO:0010043 | response to zinc ion(GO:0010043) |
0.1 | 0.3 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 4.0 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.1 | 0.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 4.8 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.1 | 0.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.3 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.3 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.1 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 7.0 | GO:0070085 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.1 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 1.5 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 4.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.7 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.4 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.1 | 0.3 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.4 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0032602 | chemokine production(GO:0032602) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.7 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 0.3 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.1 | 0.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.1 | GO:0032107 | regulation of response to extracellular stimulus(GO:0032104) regulation of response to nutrient levels(GO:0032107) |
0.1 | 12.4 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 1.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.8 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.1 | 0.6 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.1 | 0.5 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.9 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.1 | GO:0010878 | cholesterol storage(GO:0010878) |
0.1 | 2.6 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 1.6 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 0.2 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 1.0 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 1.5 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.1 | 3.8 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.2 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 | 0.1 | GO:0006312 | mitotic recombination(GO:0006312) |
0.1 | 0.5 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.1 | 33.2 | GO:0006955 | immune response(GO:0006955) |
0.1 | 0.1 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.1 | 0.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.2 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.5 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.1 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 1.5 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.5 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0032109 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.1 | 0.4 | GO:0036230 | granulocyte activation(GO:0036230) |
0.1 | 1.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 8.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.1 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.7 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.1 | 0.2 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 1.9 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.2 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.1 | 0.3 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.9 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.1 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 1.0 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 0.2 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.1 | 1.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 3.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.9 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.1 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.2 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 1.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.6 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.1 | 1.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.1 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.2 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.1 | 1.2 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.2 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.5 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.1 | 1.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.4 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.1 | 0.1 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.1 | 1.0 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.2 | GO:0033131 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.2 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 4.8 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.5 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.1 | 0.5 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.1 | 5.5 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 2.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.1 | GO:0031646 | positive regulation of neurological system process(GO:0031646) positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 1.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.5 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.7 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.1 | GO:0050864 | regulation of B cell activation(GO:0050864) |
0.1 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.5 | GO:0000279 | M phase(GO:0000279) |
0.1 | 0.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.6 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.1 | GO:0019320 | hexose catabolic process(GO:0019320) |
0.1 | 1.8 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.1 | GO:0055078 | cellular sodium ion homeostasis(GO:0006883) sodium ion homeostasis(GO:0055078) |
0.1 | 0.1 | GO:0070977 | ossification involved in bone maturation(GO:0043931) organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.1 | 0.8 | GO:0048925 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.1 | 0.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 2.0 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.1 | 2.2 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.1 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.6 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.1 | 0.3 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.2 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.1 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 2.9 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.1 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 6.5 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0019614 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) auditory receptor cell development(GO:0060117) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 1.1 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 14.9 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 0.4 | GO:0045333 | cellular respiration(GO:0045333) |
0.1 | 0.2 | GO:0021754 | facial nucleus development(GO:0021754) |
0.1 | 0.6 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.3 | GO:0032200 | telomere organization(GO:0032200) |
0.1 | 2.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 1.0 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.1 | GO:0009584 | detection of visible light(GO:0009584) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.2 | GO:0043500 | muscle adaptation(GO:0043500) |
0.1 | 1.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 1.1 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.1 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.1 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.1 | 0.3 | GO:0019751 | polyol metabolic process(GO:0019751) |
0.1 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.1 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.2 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.6 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 1.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:1903363 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) negative regulation of cellular protein catabolic process(GO:1903363) |
0.1 | 4.7 | GO:0044257 | cellular protein catabolic process(GO:0044257) |
0.1 | 0.5 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 2.1 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.1 | 0.3 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.1 | 0.1 | GO:0051412 | response to corticosterone(GO:0051412) |
0.1 | 3.3 | GO:0016032 | viral process(GO:0016032) |
0.1 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0030147 | obsolete natriuresis(GO:0030147) |
0.1 | 0.2 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.6 | GO:0044242 | cellular lipid catabolic process(GO:0044242) |
0.1 | 0.9 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 1.1 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.9 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.4 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.9 | GO:1902653 | secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.2 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.0 | 0.5 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.2 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 1.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.6 | GO:0006757 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
0.0 | 0.3 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.1 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.0 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.0 | 0.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.0 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.0 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 2.3 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.1 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.2 | GO:0006090 | pyruvate metabolic process(GO:0006090) |
0.0 | 0.8 | GO:0051321 | meiotic cell cycle(GO:0051321) meiotic cell cycle process(GO:1903046) |
0.0 | 0.2 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.7 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.0 | GO:1902115 | regulation of organelle assembly(GO:1902115) |
0.0 | 0.1 | GO:0033363 | secretory granule organization(GO:0033363) |
0.0 | 0.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.1 | GO:0042891 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.0 | 0.0 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.0 | 0.0 | GO:0098543 | detection of other organism(GO:0098543) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.0 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 1.4 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.0 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.2 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:0002697 | regulation of immune effector process(GO:0002697) |
0.0 | 0.0 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.3 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.0 | 0.0 | GO:0010224 | response to UV-B(GO:0010224) |
0.0 | 0.0 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.0 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.0 | 0.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 1.1 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.0 | 0.0 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 7.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.2 | 3.7 | GO:0072487 | MSL complex(GO:0072487) |
1.2 | 4.9 | GO:0070820 | tertiary granule(GO:0070820) |
1.1 | 2.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.9 | 11.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.9 | 2.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 2.5 | GO:0031904 | endosome lumen(GO:0031904) |
0.8 | 10.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.7 | 4.5 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.7 | 2.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.7 | 4.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.7 | 2.1 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.7 | 3.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 4.1 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.7 | 11.3 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.7 | 7.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 1.9 | GO:0032009 | early phagosome(GO:0032009) |
0.6 | 3.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 12.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.6 | 4.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.6 | 2.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 1.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.6 | 5.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.6 | 4.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.6 | 1.8 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.6 | 3.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.6 | 1.8 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.6 | 4.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.6 | 6.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.6 | 2.9 | GO:0070695 | FHF complex(GO:0070695) |
0.6 | 1.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.6 | 2.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.6 | 2.3 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.6 | 3.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 3.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.6 | 3.3 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.5 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 1.6 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.5 | 1.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 3.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 1.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.5 | 0.5 | GO:0000803 | sex chromosome(GO:0000803) |
0.5 | 1.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 2.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 4.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.5 | 5.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.5 | 9.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 3.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 4.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.4 | 1.7 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.4 | 0.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 4.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 3.2 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.4 | 1.2 | GO:0000792 | heterochromatin(GO:0000792) |
0.4 | 2.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 1.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 1.2 | GO:0005657 | replication fork(GO:0005657) |
0.4 | 1.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.4 | 8.4 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.4 | 3.8 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.4 | 1.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 0.4 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.4 | 0.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.4 | 1.5 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.4 | 1.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.4 | 1.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 4.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.4 | 2.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 2.4 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 4.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 4.0 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 1.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 1.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 1.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 1.0 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.3 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 1.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 11.6 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.3 | 16.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.3 | 1.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 1.3 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 1.6 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 16.9 | GO:0016605 | PML body(GO:0016605) |
0.3 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 0.3 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 1.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 2.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 0.9 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 2.7 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 5.3 | GO:0005844 | polysome(GO:0005844) |
0.3 | 1.2 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.3 | 0.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 1.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 0.9 | GO:0001652 | granular component(GO:0001652) |
0.3 | 0.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 18.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 0.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 3.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 0.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 5.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 2.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 2.5 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.3 | 8.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 0.8 | GO:0022624 | proteasome activator complex(GO:0008537) proteasome accessory complex(GO:0022624) |
0.3 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 1.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.3 | 0.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.3 | 8.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 7.9 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 24.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.3 | 2.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.3 | 2.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 2.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 4.3 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 11.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 1.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 2.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 1.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 2.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 1.7 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.9 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.7 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 0.9 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 4.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 10.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 2.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 0.4 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.2 | 1.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.6 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.8 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 2.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 1.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 3.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.8 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.2 | 20.1 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 1.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.4 | GO:0032059 | bleb(GO:0032059) |
0.2 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 2.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 5.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 1.2 | GO:0002102 | podosome(GO:0002102) |
0.2 | 2.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 3.1 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 1.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 3.4 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 0.9 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.2 | 3.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 23.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 1.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 17.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 0.4 | GO:0031967 | organelle envelope(GO:0031967) |
0.2 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.2 | 8.8 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 0.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.2 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.2 | 1.6 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 3.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.5 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 19.5 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 0.9 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.8 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.5 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.2 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 9.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 11.7 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 2.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 0.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 2.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 3.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.5 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 7.6 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.2 | 0.3 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 0.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 11.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 1.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 2.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 4.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 1.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 3.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.4 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 67.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 1.0 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 2.5 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 1.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 1.5 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.1 | 0.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 2.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 3.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 2.0 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 3.0 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 1.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.5 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 5.6 | GO:0005819 | spindle(GO:0005819) |
0.1 | 4.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 2.6 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 3.4 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 2.1 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.1 | 3.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.1 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 0.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 61.0 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 143.8 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 1.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 2.5 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.7 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 2.0 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.4 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.1 | 5.6 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 3.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 9.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 1.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 2.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 34.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 3.2 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 1.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 16.9 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.1 | 0.5 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 4.0 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.7 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.1 | 21.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 165.0 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 10.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.6 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 2.6 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.1 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 1.2 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.9 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.0 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 1.2 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 2.7 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.1 | GO:1990234 | transferase complex(GO:1990234) |
0.0 | 0.2 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.2 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.9 | 5.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.7 | 5.0 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.3 | 6.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.3 | 4.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.1 | 4.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.1 | 6.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.0 | 4.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.0 | 3.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
1.0 | 1.0 | GO:0004527 | exonuclease activity(GO:0004527) |
1.0 | 3.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.0 | 3.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.9 | 2.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.9 | 5.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.9 | 10.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.9 | 1.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.8 | 2.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.8 | 1.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.8 | 2.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.8 | 7.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.8 | 1.6 | GO:0005035 | death receptor activity(GO:0005035) |
0.8 | 6.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.8 | 3.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 2.3 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.7 | 5.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.7 | 3.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.7 | 2.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.7 | 5.9 | GO:0030371 | translation repressor activity(GO:0030371) |
0.7 | 12.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.7 | 4.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.7 | 2.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.7 | 2.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.7 | 3.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.7 | 0.7 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.7 | 4.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.7 | 2.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.7 | 6.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.7 | 4.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.7 | 0.7 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.7 | 12.4 | GO:0043621 | protein self-association(GO:0043621) |
0.6 | 2.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 3.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 0.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.6 | 1.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 1.9 | GO:0043398 | HLH domain binding(GO:0043398) |
0.6 | 1.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.6 | 1.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 1.8 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.6 | 3.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.6 | 1.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 1.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 2.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.6 | 2.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 4.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.6 | 1.7 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.6 | 1.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.6 | 2.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.6 | 2.3 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 2.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.6 | 2.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 3.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.5 | 1.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.5 | 2.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.5 | 5.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.5 | 1.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.5 | 2.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 1.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.5 | 2.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.5 | 1.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.5 | 1.5 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.5 | 3.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.5 | 0.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 1.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.5 | 4.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.5 | 3.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.5 | 1.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 1.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 3.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.5 | 1.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 2.9 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 1.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 1.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.5 | 1.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 2.4 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.5 | 1.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.5 | 3.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 1.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.5 | 3.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 1.4 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.5 | 1.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 3.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 1.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.5 | 1.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 4.1 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 2.7 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.5 | 3.6 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.5 | 2.3 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.4 | 4.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.4 | 0.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.4 | 2.6 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.4 | 1.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.4 | 1.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 5.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 0.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.4 | 4.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 1.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.4 | 0.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.4 | 0.8 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 2.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.4 | 1.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 3.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 1.2 | GO:0019863 | IgE binding(GO:0019863) |
0.4 | 1.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.4 | 2.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 2.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 1.6 | GO:0004340 | glucokinase activity(GO:0004340) |
0.4 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 0.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.4 | 1.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 1.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 1.2 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.4 | 1.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.4 | 1.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.4 | 1.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 19.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 2.8 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.4 | 1.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 1.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 1.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.4 | 9.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 2.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 1.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 2.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 1.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.4 | 1.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 1.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 4.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 3.4 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.4 | 2.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 4.1 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.4 | 1.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 3.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 1.1 | GO:0001012 | transcription regulatory region sequence-specific DNA binding(GO:0000976) RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.4 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.4 | 0.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.4 | 1.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 1.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 4.6 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.4 | 10.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 1.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 0.7 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.4 | 1.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 1.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 4.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 5.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.3 | 1.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.3 | 1.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 2.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 3.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.3 | 1.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 5.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 2.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 1.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 1.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 5.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 1.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 1.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 5.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 12.7 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.3 | 1.7 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.3 | 1.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 0.7 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 1.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 1.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 2.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 1.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 1.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 1.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 1.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 2.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 1.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 0.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 1.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 1.9 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.9 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.3 | 3.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 10.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 0.9 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.3 | 1.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.3 | 1.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.3 | 5.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 3.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 2.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 7.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 4.8 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.3 | 0.9 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.3 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 5.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 1.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.3 | 1.2 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 1.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.3 | 1.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 2.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 0.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 1.8 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.3 | 0.9 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 2.6 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.3 | 1.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 0.9 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.3 | 0.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 2.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 1.4 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.3 | 4.0 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 0.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 0.9 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 1.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 0.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 1.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 0.9 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 0.8 | GO:0045569 | TRAIL binding(GO:0045569) |
0.3 | 2.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 1.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.3 | 3.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 0.6 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.3 | 1.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 0.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 1.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 0.5 | GO:0051379 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
0.3 | 1.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 4.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 10.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 3.8 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.3 | 7.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 0.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.3 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 4.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 1.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 1.0 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 0.3 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.3 | 2.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 1.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 0.8 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.3 | 2.0 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 1.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 2.0 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 1.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 3.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 1.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 1.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 2.0 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.7 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 4.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 1.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 3.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 1.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 6.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 5.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 4.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 2.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 1.6 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 1.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 1.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 2.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 2.3 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.2 | 2.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.7 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 0.7 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.2 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 1.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 5.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 1.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 1.8 | GO:0019900 | kinase binding(GO:0019900) |
0.2 | 0.7 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 1.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 2.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 4.6 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.2 | 0.9 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 0.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 5.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 7.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.6 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.2 | 2.5 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.2 | 0.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 3.5 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 3.7 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.2 | 0.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 1.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 0.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 1.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.6 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.2 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 2.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.8 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.6 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 8.8 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 1.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 1.0 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.4 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.2 | 1.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.2 | 0.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 1.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.2 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.6 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.2 | 0.7 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 3.1 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 0.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 3.8 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 7.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 18.8 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.2 | 3.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 1.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 1.1 | GO:0090079 | translation activator activity(GO:0008494) translation regulator activity, nucleic acid binding(GO:0090079) |
0.2 | 0.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 2.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 22.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.2 | 1.1 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.2 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 4.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 5.7 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.2 | 3.2 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.2 | 1.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 13.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 3.2 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 2.4 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.2 | 0.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 1.4 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 0.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.2 | 1.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.5 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.2 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 1.9 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 6.2 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.2 | 2.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.5 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 3.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.3 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.2 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 2.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.2 | 1.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 2.4 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.2 | 0.6 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 2.3 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.2 | 0.6 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.2 | 6.7 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.2 | 3.5 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 3.5 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.2 | 0.5 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 1.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 0.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 1.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 1.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 10.1 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.2 | 0.9 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.2 | 0.3 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 6.6 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.2 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 1.7 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.0 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 1.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 2.3 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 1.8 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.7 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.7 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 1.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.3 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.3 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.1 | 2.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 1.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.4 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 11.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.7 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 2.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 2.2 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 2.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 2.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.8 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.6 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 1.8 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.5 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 5.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.5 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.1 | 2.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 5.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 1.0 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 1.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.7 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.1 | 0.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 2.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 55.4 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.3 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.3 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) thiamine pyrophosphate binding(GO:0030976) |
0.1 | 1.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 1.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 1.6 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 2.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 1.0 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 2.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 2.5 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 1.0 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.2 | GO:0003917 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
0.1 | 1.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.2 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 0.3 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.1 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 7.2 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 7.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 2.6 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 1.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 7.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.5 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 7.3 | GO:0019901 | protein kinase binding(GO:0019901) |
0.1 | 1.8 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 12.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.2 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 9.8 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 17.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 8.7 | GO:0016874 | ligase activity(GO:0016874) |
0.1 | 0.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.7 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 1.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.3 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 9.2 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 3.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 1.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.9 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.6 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
0.1 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.2 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.1 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 0.4 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 1.0 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.5 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 81.6 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 3.5 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.1 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.9 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 1.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.2 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.7 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.2 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.8 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.4 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 1.1 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.0 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.5 | GO:0044389 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 1.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.1 | 50.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.1 | 31.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.0 | 1.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.8 | 8.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.8 | 11.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.7 | 5.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 10.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 20.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.7 | 26.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.6 | 10.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.6 | 9.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 12.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.6 | 1.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 2.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.6 | 8.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.6 | 7.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 3.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.6 | 2.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 3.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 7.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 10.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.5 | 12.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 11.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 4.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.5 | 8.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 3.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 6.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 2.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 1.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 4.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 18.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 4.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 2.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 1.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 2.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.4 | 11.0 | PID FOXO PATHWAY | FoxO family signaling |
0.4 | 11.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 4.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 3.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 2.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 1.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 2.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 1.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 1.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 6.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 11.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 13.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 5.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 1.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 10.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 7.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 2.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 11.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 7.7 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 2.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 3.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 1.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 4.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 1.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 6.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 1.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 0.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 2.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 3.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 1.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 1.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 8.1 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 3.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 2.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 5.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 5.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 1.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 1.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 5.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 1.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 3.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 3.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 5.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.1 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 1.5 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.3 | 1.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.2 | 19.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.2 | 1.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.0 | 1.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.0 | 1.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.9 | 15.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.9 | 2.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.9 | 9.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.9 | 0.9 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.8 | 1.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.8 | 8.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.8 | 10.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.7 | 18.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.7 | 1.4 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.6 | 5.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 0.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.6 | 7.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.6 | 1.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.6 | 3.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.6 | 0.6 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.6 | 6.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.6 | 6.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.5 | 26.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.5 | 6.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 1.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 6.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.5 | 1.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.5 | 7.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 19.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.5 | 6.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 9.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.5 | 4.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 4.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.4 | 1.8 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.4 | 2.2 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.4 | 4.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 8.0 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.4 | 2.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.4 | 8.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.4 | 20.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 9.6 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.4 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 2.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 4.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 9.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 5.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 14.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 10.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 6.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 3.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 1.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 4.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 1.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 2.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 7.9 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.3 | 5.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 6.0 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.3 | 1.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 5.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 7.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 1.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 7.4 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.3 | 5.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 10.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.3 | 0.3 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.3 | 6.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 5.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 4.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.3 | 0.9 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.3 | 2.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 6.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 1.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 6.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 1.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 0.6 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.3 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 8.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 2.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 2.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 3.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 4.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 1.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 7.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 4.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 3.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 3.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 2.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 22.7 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 0.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 3.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.2 | 2.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 2.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 1.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 11.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 2.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 3.7 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 3.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 5.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 1.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 6.5 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.2 | 1.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 1.1 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.2 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 2.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 2.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 1.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 4.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 2.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 17.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 24.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 3.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 3.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 2.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 3.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 3.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 1.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 2.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 1.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 1.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 2.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 0.8 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 1.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 2.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 2.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 2.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 5.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 3.6 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 8.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 2.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 3.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 10.4 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 0.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 2.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.4 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 8.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 2.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.1 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.1 | 1.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.8 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 0.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 2.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 1.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.3 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 3.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 7.2 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 2.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 2.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 2.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 5.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.5 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.1 | 1.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 2.3 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 1.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 8.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.1 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.1 | 3.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 3.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.3 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.1 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 3.1 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 1.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 2.3 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.2 | REACTOME CELL CYCLE | Genes involved in Cell Cycle |
0.1 | 1.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 3.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 2.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 2.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.1 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 0.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.7 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 1.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |